Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameJenscare-B
Stock Code09877
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們是一家立足中國的醫療器械公司,致力於開發用於治療結構性心臟病的介入產品。公司已開發出針對不同類型結構性心臟病(包括三尖瓣疾病、主動脈瓣疾病、二尖瓣疾病及心力衰竭)的一系列治療解決方案。
Listing Date2022-10-10
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)浙江省寧波市杭州灣新區濱海四路777號B區5號樓
Business Address (Hong Kong)香港灣仔皇后大道東248號大新金融中心40樓
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitejenscare.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 27.80 / shares
Offer Price RangeFinal offer price only, no range
Lot Size1 shares
Entry ThresholdHK$ 27
Par ValueRMB 1.0 / shares
Offer Period2022-09-23 to 2022-09-29
Global Offering Shares8,076,400 shares
HK Public Offer Shares (Initial)808,000 shares (10.0%)
Public Offer Lots (Initial)808,000lots (Pool A404,000lots,Pool B404,000lots)
International Placing Shares (Initial)7,268,400 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO417,167,290 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share69.9%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 224,523,920

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 1 HK$ 28
200 lots 200 HK$ 5,560
400 lots 400 HK$ 11,120
600 lots 600 HK$ 16,680
800 lots 800 HK$ 22,240
1,000 lots 1,000 HK$ 27,800
1,200 lots 1,200 HK$ 33,360
1,294 lots 1,294 HK$ 35,973
1,400 lots 1,400 HK$ 38,920
1,600 lots 1,600 HK$ 44,480
1,800 lots 1,800 HK$ 50,040
2,000 lots 2,000 HK$ 55,600
3,000 lots 3,000 HK$ 83,400
4,000 lots 4,000 HK$ 111,200
5,000 lots 5,000 HK$ 139,000
6,000 lots 6,000 HK$ 166,800
7,000 lots 7,000 HK$ 194,600
8,000 lots 8,000 HK$ 222,400
10,000 lots 10,000 HK$ 278,000
50,000 lots 50,000 HK$ 1,390,000
160,000 lots 160,000 HK$ 4,448,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
404,000 lots 404,000 HK$ 11,231,200

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 2.37B
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +309%

Valuation & Financials

Market Cap (at Offer Price)HK$ 11,597,250,662
H-Share Market Cap (at Offer Price)HK$ 3,658,219,569
Pre-IPO Valuation (Last Round)Not disclosed
P/E Ratio不适用(公司处于亏损状态)
Profit/Loss Status亏损人民币500.7百万元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 202020212022
Other income and gains, net 3,0708,91038,346
Administrative expenses -131,476-238,506-40,534
Net finance costs -594-130-50
Share of associates and JVs 01,34313,549
Profit before tax -299,673-500,673-73,529
Income tax expense 000
Profit for the year -299,673-500,673-73,529
Profit attributable to owners -299,447-500,517-72,853
Balance Sheet
Item 202020212022-06
Cash and cash equivalents 349,067800,590
Inventories 1,5204,672
Total current assets 355,186828,805
Total assets 372,8431,341,359
Total current liabilities 18,35649,700
Total liabilities 20,06050,768
Total equity 352,7831,290,591
Equity attributable to owners 352,7831,290,747
Interest-bearing borrowings 61100
Cash Flow Statement
Item 202020212022-062022
Net cash from operating activities -46,853-141,894-58,018
Net cash from investing activities 6,619-475,073-372,006
Net cash from financing activities 383,5141,075,326-431
Net increase in cash 343,280458,359-430,455
Depreciation of PP&E 2,4443,4072,754
Depreciation of right-of-use assets 8851,7041,173
Amortisation of intangible assets 13150146
Purchase of PP&E -2,092-13,278-12,699
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 28.25
First Day OpenHK$ 28.0
First Day Change1.62%
First Day Volume1466000.0
First Day Turnover41947900.0
Use of Proceeds
1、約65.0%或約100.6百萬港元將分配予我們核心產品(即LuX-Valve及KenValve)的研發、制造及商業化; 2、約25.0%或約38.7百萬港元將分配予產品管線的其他在研產品(包括LuXValve Plus、KenFlex及二尖瓣產品)的研發、臨床試驗及產品注冊; 3、約10.0%或約15.5百萬港元將用于營運資金及一般企業用途。

Underwriting Syndicate

Joint Sponsors (2)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 Citigroup Global Markets Asia Limited CE AAA137
Overall Coordinators (4)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 Citigroup Global Markets Asia Limited CE AAA137 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 农银国际证券有限公司 CE ACX411
Joint Bookrunners (7)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 Citigroup Global Markets Asia Limited CE AAA137 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 农银国际证券有限公司 CE ACX411 交银国际证券有限公司 CE APJ121 富途证券国际(香港)有限公司 CE AZT137 老虎证券(香港)环球有限公司 CE BMU940
Joint Lead Managers (8)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 Citigroup Global Markets Asia Limited CE AAA137 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 农银国际证券有限公司 CE ACX411 交银国际证券有限公司 CE APJ121 富途证券国际(香港)有限公司 CE AZT137 老虎证券(香港)环球有限公司 CE BMU940 SILVERBRICKS SECURITIES COMPANY LIMITED CE BLN458

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 先健科技公司 156,975,480 HKD — 69.91% — 6 months 2023-04-10

Directors & Management

PositionChinese nameEnglish Name
Chairman呂世文—
Company Secretary李遠源—
No director data available.

Major Shareholders

Major Shareholders & Holdings控股股东为吕世文先生与李女士(一致行动人),合计持有本公司约50.53%股份。其他主要股东包括宁波迪翔、上海仕地、海南脉迪、宁波桑迪、宁波沐康、宁波麟灃等员工持股平台,以及高瓴资本、AUT-VII HK Holdings Limited等机构投资者。
About this page

This page shows Jenscare-B (09877) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect